Jim Wassil
CIK: 0001813798
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Vaxcyte, Inc.
Discretionary Trading P&L
Holdings
Transaction History (89 total)
- Oct 5, 2026PCVX
Vaxcyte, Inc.
Sale(S)Direct18K shares at avg. $86.74$1.6M - Oct 5, 2026PCVX
Vaxcyte, Inc.
Exercise(M)Direct18K shares at avg. $5.35$96K - Oct 1, 2026PCVX
Vaxcyte, Inc.
Sale(S)Direct95 shares at avg. $57.09$5K - Oct 1, 2026PCVX
Vaxcyte, Inc.
Sale(S)Direct2.2K shares at avg. $56.65$122K - Oct 1, 2026PCVX
Vaxcyte, Inc.
Exercise(M)Direct2.3K shares at avg. $5.35$12K - Sep 9, 2026PCVX
Vaxcyte, Inc.
Sale(S)Direct1.3K shares at avg. $59.52$79K - Sep 8, 2026PCVX
Vaxcyte, Inc.
Tax Payment(F)Direct5.5K shares at avg. $60.36$330K - Sep 4, 2026PCVX
Vaxcyte, Inc.
Sale(S)Direct1.4K shares at avg. $61.16$84K - Sep 2, 2026PCVX
Vaxcyte, Inc.
Tax Payment(F)Direct1.4K shares at avg. $61.58$88K - Sep 1, 2026PCVX
Vaxcyte, Inc.
Sale(S)Direct924 shares at avg. $60.95$56K - Sep 1, 2026PCVX
Vaxcyte, Inc.
Sale(S)Direct1.5K shares at avg. $60.89$94K - Sep 1, 2026PCVX
Vaxcyte, Inc.
Exercise(M)Direct2.3K shares at avg. $5.35$12K - Sep 1, 2026PCVX
Vaxcyte, Inc.
Sale(S)Direct713 shares at avg. $61.48$44K - Sep 1, 2026PCVX
Vaxcyte, Inc.
Sale(S)Direct303 shares at avg. $61.42$19K - Aug 31, 2026PCVX
Vaxcyte, Inc.
Tax Payment(F)Direct1.3K shares at avg. $60.74$77K - Aug 3, 2026PCVX
Vaxcyte, Inc.
Sale(S)Direct861 shares at avg. $53.50$46K - Aug 3, 2026PCVX
Vaxcyte, Inc.
Exercise(M)Direct2.3K shares at avg. $5.35$12K - Aug 3, 2026PCVX
Vaxcyte, Inc.
Sale(S)Direct1.4K shares at avg. $54.09$75K - Jul 1, 2026PCVX
Vaxcyte, Inc.
Sale(S)Direct456 shares at avg. $57.47$26K - Jul 1, 2026PCVX
Vaxcyte, Inc.
Sale(S)Direct6 shares at avg. $57.82$346.92 - Jul 1, 2026PCVX
Vaxcyte, Inc.
Sale(S)Direct1.8K shares at avg. $56.03$100K - Jul 1, 2026PCVX
Vaxcyte, Inc.
Exercise(M)Direct516 shares at avg. $5.35$3K - Jun 1, 2026PCVX
Vaxcyte, Inc.
Sale(S)Direct301 shares at avg. $50.26$15K - Jun 1, 2026PCVX
Vaxcyte, Inc.
Sale(S)Direct1.9K shares at avg. $49.40$96K - May 1, 2026PCVX
Vaxcyte, Inc.
Sale(S)Direct2.3K shares at avg. $56.83$128K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 5, 2026 | PCVX Vaxcyte, Inc. | Sale(S) | 18,000 | $86.74 | $1,561,320 | Direct |
| Oct 5, 2026 | PCVX Vaxcyte, Inc. | Exercise(M) | 18,000 | $5.35 | $96,300 | Direct |
| Oct 1, 2026 | PCVX Vaxcyte, Inc. | Sale(S) | 95 | $57.09 | $5,424 | Direct |
| Oct 1, 2026 | PCVX Vaxcyte, Inc. | Sale(S) | 2,155 | $56.65 | $122,089 | Direct |
| Oct 1, 2026 | PCVX Vaxcyte, Inc. | Exercise(M) | 2,250 | $5.35 | $12,038 | Direct |
| Sep 9, 2026 | PCVX Vaxcyte, Inc. | Sale(S) | 1,334 | $59.52 | $79,401 | Direct |
| Sep 8, 2026 | PCVX Vaxcyte, Inc. | Tax Payment(F) | 5,459 | $60.36 | $329,505 | Direct |
| Sep 4, 2026 | PCVX Vaxcyte, Inc. | Sale(S) | 1,381 | $61.16 | $84,462 | Direct |
| Sep 2, 2026 | PCVX Vaxcyte, Inc. | Tax Payment(F) | 1,432 | $61.58 | $88,183 | Direct |
| Sep 1, 2026 | PCVX Vaxcyte, Inc. | Sale(S) | 924 | $60.95 | $56,322 | Direct |
| Sep 1, 2026 | PCVX Vaxcyte, Inc. | Sale(S) | 1,537 | $60.89 | $93,582 | Direct |
| Sep 1, 2026 | PCVX Vaxcyte, Inc. | Exercise(M) | 2,250 | $5.35 | $12,038 | Direct |
| Sep 1, 2026 | PCVX Vaxcyte, Inc. | Sale(S) | 713 | $61.48 | $43,836 | Direct |
| Sep 1, 2026 | PCVX Vaxcyte, Inc. | Sale(S) | 303 | $61.42 | $18,611 | Direct |
| Aug 31, 2026 | PCVX Vaxcyte, Inc. | Tax Payment(F) | 1,273 | $60.74 | $77,322 | Direct |
| Aug 3, 2026 | PCVX Vaxcyte, Inc. | Sale(S) | 861 | $53.50 | $46,065 | Direct |
| Aug 3, 2026 | PCVX Vaxcyte, Inc. | Exercise(M) | 2,250 | $5.35 | $12,038 | Direct |
| Aug 3, 2026 | PCVX Vaxcyte, Inc. | Sale(S) | 1,389 | $54.09 | $75,130 | Direct |
| Jul 1, 2026 | PCVX Vaxcyte, Inc. | Sale(S) | 456 | $57.47 | $26,208 | Direct |
| Jul 1, 2026 | PCVX Vaxcyte, Inc. | Sale(S) | 6 | $57.82 | $347 | Direct |
| Jul 1, 2026 | PCVX Vaxcyte, Inc. | Sale(S) | 1,788 | $56.03 | $100,182 | Direct |
| Jul 1, 2026 | PCVX Vaxcyte, Inc. | Exercise(M) | 516 | $5.35 | $2,761 | Direct |
| Jun 1, 2026 | PCVX Vaxcyte, Inc. | Sale(S) | 301 | $50.26 | $15,127 | Direct |
| Jun 1, 2026 | PCVX Vaxcyte, Inc. | Sale(S) | 1,949 | $49.40 | $96,288 | Direct |
| May 1, 2026 | PCVX Vaxcyte, Inc. | Sale(S) | 2,250 | $56.83 | $127,870 | Direct |
1-25 of 89 transactions
About Wassil Jim
Wassil Jim (SEC CIK 0001813798) files insider reports with the SEC as EVP, Chief Scientific Ofc, COO of Vaxcyte, Inc. (PCVX).
Signal8 holds 24 ownership filings by Wassil Jim, all Form 4s, filed between Sep 5, 2024 and Oct 7, 2026. Those filings report 89 transactions, from Sep 3, 2024 to Oct 5, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Wassil Jim's filings is in SAN CARLOS, CA.
Recent filings by Wassil Jim
- Oct 5, 2026: Open-market sale of PCVX shares (Form 4, code S).
- Oct 5, 2026: Option exercise of PCVX shares (Form 4, code M).
- Oct 1, 2026: Open-market sales of PCVX shares (2 lines, Form 4, code S).
- Oct 1, 2026: Option exercise of PCVX shares (Form 4, code M).
- Sep 9, 2026: Open-market sale of PCVX shares (Form 4, code S).
Other insiders filing for Vaxcyte, Inc. (PCVX)
- Cowan Elvia, SVP, Finance & CAO
- PICKERING GRANT, CHIEF EXECUTIVE OFFICER
- GUGGENHIME ANDREW, PRESIDENT AND CFO
- Dhaliwal Harpreet S., Chief Technical Ops Officer
- Jodar Luis, Chief Medical Officer
- Markels John, Director